These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28258578)

  • 21. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future.
    Mangiatordi GF; Alberga D; Trisciuzzi D; Lattanzi G; Nicolotti O
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypharmacology Approach Against Migraine with Aura and Brain Edema for the Development of an Efficient Inhibitor and its Analogues.
    Rizwan S; Mehmood A; Khalid I; Khan MS; Yousafi Q; Kalsoom S; Rashid H
    Curr Comput Aided Drug Des; 2018; 14(4):385-390. PubMed ID: 29756582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles for novel pharmacological blockers of aquaporins in the treatment of brain oedema and cancer.
    Yool AJ; Brown EA; Flynn GA
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):403-9. PubMed ID: 19566827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Roles of Aquaporins in Brain Disorders].
    Yasui M
    Brain Nerve; 2015 Jun; 67(6):733-8. PubMed ID: 26062588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of aquaporins in cell migration and edema formation in human brain tumors.
    Nico B; Ribatti D
    Exp Cell Res; 2011 Oct; 317(17):2391-6. PubMed ID: 21784068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of water channel proteins in selected neurological disorders: epilepsies, muscular dystrophies, amyotrophic lateral sclerosis, neuromyelitis optica, Parkinson's disease, and spongiform encephalopathies.
    Benga I; Benga O
    Mol Aspects Med; 2012; 33(5-6):590-604. PubMed ID: 22484281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
    Huber VJ; Tsujita M; Nakada T
    Bioorg Med Chem; 2009 Jan; 17(1):411-7. PubMed ID: 18182301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spectrum of neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
    Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered astrocytic swelling in the cortex of α-syntrophin-negative GFAP/EGFP mice.
    Anderova M; Benesova J; Mikesova M; Dzamba D; Honsa P; Kriska J; Butenko O; Novosadova V; Valihrach L; Kubista M; Dmytrenko L; Cicanic M; Vargova L
    PLoS One; 2014; 9(11):e113444. PubMed ID: 25426721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Molecular Mechanisms of the Rapid Tonicity-induced Relocalization of the Aquaporin 4 Channel.
    Kitchen P; Day RE; Taylor LH; Salman MM; Bill RM; Conner MT; Conner AC
    J Biol Chem; 2015 Jul; 290(27):16873-81. PubMed ID: 26013827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propofol administration modulates AQP-4 expression and brain edema after traumatic brain injury.
    Ding Z; Zhang J; Xu J; Sheng G; Huang G
    Cell Biochem Biophys; 2013 Nov; 67(2):615-22. PubMed ID: 23494261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromyelitis optica (Devic's syndrome).
    Wingerchuk DM; Weinshenker BG
    Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
    Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intractable vomiting as the initial presentation of neuromyelitis optica.
    Apiwattanakul M; Popescu BF; Matiello M; Weinshenker BG; Lucchinetti CF; Lennon VA; McKeon A; Carpenter AF; Miller GM; Pittock SJ
    Ann Neurol; 2010 Nov; 68(5):757-61. PubMed ID: 21031587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
    Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
    Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?
    Bradl M; Lassmann DH
    Int MS J; 2008 Sep; 15(3):75-8. PubMed ID: 18812056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis Optica.
    Ju EJ; Yeon SK; Park JH; Cheon SY; Choi JW; Ha T; Jang BK; Kim S; Kang YG; Hwang H; Cho SJ; Cheong E; Bahn YS; Pae AN; Kim SM; Park KD
    ChemMedChem; 2016 Feb; 11(4):377-81. PubMed ID: 26804736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.